Abstract PS10-44: Termination of trastuzumab-based treatment after complete response in HER2-positive metastatic breast cancer

Authors: Izzet Dogan, Esra Aydın, Nijat Khanmammadov, Adnan Aydıner, Pınar Saip

Published: 2021-02-15

DOI: 10.1158/1538-7445.sabcs20-ps10-44

Source: Full article